US equities
|
NVDA
$204.64
▼-4.22%
INTC
$65.76
▼-28.58%
MU
$884.74
▼-5.30%
AMZN
$240.35
▼-1.41%
AAPL
$344.63
▼-1.23%
SNDK
$1,150.89
▼-13.47%
AMD
$504.80
▼-10.88%
MSFT
$521.91
▼-1.55%
NVDA
$204.64
▼-4.22%
INTC
$65.76
▼-28.58%
MU
$884.74
▼-5.30%
AMZN
$240.35
▼-1.41%
AAPL
$344.63
▼-1.23%
SNDK
$1,150.89
▼-13.47%
AMD
$504.80
▼-10.88%
MSFT
$521.91
▼-1.55%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Articles published by MilliporeSigma
MilliporeSigma Announces the Opening of €300 Million Asia-Pacific Bioprocessing Production Center in Daejeon, South Korea
October 29, 2026
From
MilliporeSigma
Via
GlobeNewswire
MilliporeSigma Announces Opening of BioReliance® Testing Facility in Darmstadt, Germany to Support Drug Product Release in Europe
July 16, 2026
From
MilliporeSigma
Via
GlobeNewswire
MilliporeSigma Announces Hiba Therapeutics as Winner of 2026 North American Advance Biotech Grant
June 24, 2026
From
MilliporeSigma
Via
GlobeNewswire
MilliporeSigma Appoints New Heads of Discovery Solutions and Strategy & Business Development
June 08, 2026
From
MilliporeSigma
Via
GlobeNewswire
MilliporeSigma Becomes Sole Testing Provider for Genetix Biotherapeutics’ FDA-Approved Gene Therapies
May 07, 2026
From
MilliporeSigma
Via
GlobeNewswire
MilliporeSigma Launches First Bio-Based Solvent Portfolio for High-Performance Liquid Chromatography
April 21, 2026
From
MilliporeSigma
Via
GlobeNewswire
MilliporeSigma Completes Acquisition of JSR Life Sciences’ Chromatography Business, Expanding Protein A Capabilities and Downstream Portfolio
April 01, 2026
From
MilliporeSigma
Via
GlobeNewswire
MilliporeSigma Marks 10 Years of SPARK™ Mobilizing Employee Volunteers to Help Inspire the Next Generation in STEM
March 18, 2026
From
MilliporeSigma
Via
GlobeNewswire
MilliporeSigma Partners with Promega to Advance 3-D Cell Drug Discovery Technologies
October 28, 2025
From
MilliporeSigma
Via
Business Wire
MilliporeSigma to Acquire Chromatography Business of JSR Life Sciences, Expanding Protein A Capabilities and Downstream Portfolio
October 15, 2025
From
MilliporeSigma
Via
Business Wire
MilliporeSigma and Washington University in St. Louis Sign MoU to Advance Scientific Collaboration
July 24, 2025
From
MilliporeSigma
Via
Business Wire
MilliporeSigma Launches AAW™ Workstation to Advance Lab Automation
July 15, 2025
From
MilliporeSigma
Via
Business Wire
MilliporeSigma Announces Neoclease as Winner of 2025 North American Advance Biotech Grant
June 18, 2025
From
MilliporeSigma
Via
Business Wire
Curiosity Cube 2025: MilliporeSigma’s Mobile Science Labs Tour Globally to Bring STEM Education to Students
April 24, 2025
From
MilliporeSigma
Via
Business Wire
MilliporeSigma Partners with Opentrons Labworks, Inc., Supporting Lab of the Future
January 23, 2025
From
MilliporeSigma
Via
Business Wire
MilliporeSigma Acquires HUB Organoids Holding B.V., Expands Next-Gen Biology Portfolio
January 06, 2025
From
MilliporeSigma
Via
Business Wire
MilliporeSigma to Acquire HUB Organoids Holding B.V., Advancing Next Generation Biology Portfolio
December 17, 2024
From
MilliporeSigma
Via
Business Wire
MilliporeSigma Invests $76 Million to Expand ADC Manufacturing for Novel Cancer Therapies
October 29, 2024
From
MilliporeSigma
Via
Business Wire
MilliporeSigma Opens New €290 Million Biosafety Testing Facility in Rockville, Maryland, USA
October 09, 2024
From
MilliporeSigma
Via
Business Wire
MilliporeSigma Launches Single-Use Reactor Designed to Accelerate Antibody Drug Conjugate Manufacturing
September 10, 2024
From
MilliporeSigma
Via
Business Wire
MilliporeSigma Receives Industry First EXCiPACT Certification for Cell Culture Media Manufacturing
September 03, 2024
From
MilliporeSigma
Via
Business Wire
MilliporeSigma Announces Closing of Mirus Bio Acquisition, Bolstering Viral Vector Bioprocessing Offering
August 01, 2024
From
MilliporeSigma
Via
Business Wire
MilliporeSigma and The Michael J. Fox Foundation Offer Service to Advance Parkinson’s Research
June 18, 2024
From
MilliporeSigma
Via
Business Wire
MilliporeSigma Announces Siren Biotechnology as Winner of its North American Advance Biotech Grant
June 04, 2024
From
MilliporeSigma
Via
Business Wire
MilliporeSigma Launches First Software for Complete Data Traceability in Microbial Quality Control
May 28, 2024
From
MilliporeSigma
Via
Business Wire
MilliporeSigma Signs Definitive Agreement to Acquire Mirus Bio, Furthering Ambition to Be a Leading Supplier for Viral Vector Manufacturing
May 22, 2024
From
MilliporeSigma
Via
Business Wire
MilliporeSigma Inspires Students to Explore STEM Careers with 2024 Curiosity Cube Tour
April 17, 2024
From
MilliporeSigma
Via
Business Wire
MilliporeSigma Launches First All-in-One Genetic Stability Assay to Accelerate Biosafety Testing
April 16, 2024
From
MilliporeSigma
Via
Business Wire
MilliporeSigma Invests More than € 300 Million in New Life Science Production Site in Korea
March 20, 2024
From
MilliporeSigma
Via
Business Wire
